102 top medical experts on Carnitine-Acylcarnitine Translocase Deficiency across 13 countries and 1 U.S. states, including 5 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Carnitine-Acylcarnitine Translocase Deficiency: Carnitine-acylcarnitine translocase (CACT) deficiency is a life-threatening, inherited disorder of fatty acid oxidation which usually presents in the neonatal period with severe hypoketotic hypoglycemia, hyperammonemia, cardiomyopathy and/or arrhythmia, hepatic dysfunction, skeletal muscle weakness, and encephalopathy.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations

Organizations Providing General Support

  • Synonyms: CACT Deficiency,  Carnitine Acylcarnitine Translocase Deficiency,  Carnitine-Acylcarnitine Carrier Deficiency


    •   

            

                        


      Computing Expert Listing ...